Its not flashy
Understanding the nuanced differences between these therapies is crucial for making an informed decision about your health journey
It is the active ingredient in Vyleesi, which the FDA approved in 2019 for hypoactive sexual desire disorder in premenopausal women
If you have questions about your coverage or next steps, please reach out to us directly
Disclaimer: Information and statements regarding the product/services have not been evaluated by the Food and Drug Administration or any government authority and not intended to diagnose, treat, cure, or prevent any disease_ Product/Services reviews are provided by users based on their persona, experiences & opinions, and do not reflect the opinion of HealthKart_ Product/Services information provided by the seller on HealthKart is not exhaustive, please read the label on the product carefully for complete information provided by the manufacturer_ The results from the products will vary from person to person_ No individual result should be seen as typical_
With continued medication use, spontaneous resolution has been documented at four to six weeks and up to four months